AXP
57
-2
CF
41
3
FSLR
32
-14
FIS
60
-3
LMT
42
5
AMAT
38
-4
MS
55
-2
COST
41
-3
AMGN
23
-8
DVA
52
-5
CHD
42
-6
ADM
36
2
ABBV
37
-3
CSX
33
-3
BA
33
2
EIX
40
-2
VIX
71
5
MKC
48
-5
HD
40
-3
INTU
56
-5
AXP
57
-2
CF
41
3
FSLR
32
-14
FIS
60
-3
LMT
42
5
AMAT
38
-4
MS
55
-2
COST
41
-3
AMGN
23
-8
DVA
52
-5
CHD
42
-6
ADM
36
2
ABBV
37
-3
CSX
33
-3
BA
33
2
EIX
40
-2
VIX
71
5
MKC
48
-5
HD
40
-3
INTU
56
-5
Financhill
Back

ORIC Pharmaceuticals 10K Form

Sell
14

ORIC
ORIC Pharmaceuticals

Last Price:
$4.70
Seasonality Move:
-1.09%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ORIC News And Ratings

See the #1 stock for the next 7 days that we like better than ORIC

ORIC Financial Statistics

Sales & Book Value

Annual Sales: --
Cash Flow: $-28.3M
Price / Cash Flow: 0
Annual Sales: $3.42
Price / Book: 1.37

Profitability

EPS (TTM): -1.82000
Net Income (TTM): $-127.8M
Gross Margin: --
Return on Equity: 0%
Return on Assets: 0%

ORIC Pharmaceuticals Earnings Forecast

Key ORIC Pharmaceuticals Financial Ratios

  • Per Share Earnings over the last 7 years have been positive in 3 years.

ORIC Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: ORIC
CUSIP: 68622P
Website: oricpharma.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ORIC Technical Analysis vs Fundamental Analysis

Sell
14
ORIC Pharmaceuticals (ORIC) is a Sell

Is ORIC Pharmaceuticals a Buy or a Sell?